• Home
  • Stocks
  • Welcure Drugs & Pharmaceuticals Ltd.

Welcure Drugs & Pharmaceuticals Ltd.

View in App
4.14 +0.20 ▲5.1%

01 December 2023, 04:01:00 PM
Volume: 22,137

Company Profile

View details >>
Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.welcuredrugs.com
Market Cap 5.59 Cr.
Enterprise Value(EV) 5.59 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.03 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 159.83 Trailing Twelve Months Ending 2023-09
Industry PE 70.99 Trailing Twelve Months Ending 2023-09
Book Value / Share 1.08 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.84 Calculated using Price: 4.14
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.35 Cr. 13,512,100 Shares
FaceValue 10
About Welcure Drugs & Pharmaceuticals Ltd.
Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992.

Welcure Drugs & Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Welcure Drugs & Pharmaceuticals Ltd. Performance

View details >>
1 Day
+5.08%
1 Week
+2.22%
1 Month
+5.61%
3 Month
+6.43%
6 Month
+4.28%
1 Year
-14.29%
2 Year
-50.83%
5 Year
+613.79%
10 Year
+354.95%

Welcure Drugs & Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 108.61 -65.80 17.83 -49.46 131.74 29.03 12.65
Return on Capital Employed (%) 108.91 -65.46 18.22 -48.94 131.94 29.12 12.67
Return on Assets (%) 10.40 227.41 94.50 -58.62 14.57 -34.54 112.99 27.77 12.51

Welcure Drugs & Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 0 0 0 0 0 0 0 2 1
Non Curr. Liab.
Curr. Liab. 0 0 0 0 0
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 2 1
Non Curr. Assets 0 2 1
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 2 1

Welcure Drugs & Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 0 0 0 0 0 0 0 0
Other Income 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0
Interest
Depreciation 0
Taxation
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0

Welcure Drugs & Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 1
Cash Fr. Finan. -1
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Welcure Drugs & Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 14.12 14.12 14.12 14.12 0.00 0.00 0.00 0.00 0.00
Public 85.88 85.88 85.88 85.88 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Welcure Drugs & Pharmaceuticals Ltd. Announcements

View details >>
Thu, 16 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to the above mentioned captioned subject we are hereby submitting the clippings of the English Newspaper "Financial Express" and Hindi newspaper " Jansatta" dated 16th November 2023 in which Un-Audited Financial Results for the quarter and half year ended 30th September 2023 have been published.
Tue, 14 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting Dated 14.11.2023
It is to inform you that following are the outcome of the Board Meeting held today i.e. Tuesday 14th November 2023 at 3:00 PM and concluded at 5.00 PM at the registered office of the Company.1. The Board approved the Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2023.2. The Board reviewed and took on record the Limited Review Report on the Un-Audited Financial Results of the Company for the quarter and half year ended 30th September 2023.3.The Board considered the change of Address where all or any books of A/c and papers are maintained .4. The Board considered and accepted the Resignation of Mr. Krishnan J Iyer.5. The Board considered and accepted the Resignation of Mr. Faisal S. Shaikh.6. The Board considered the recommendation for appointment of Mr. Suraj Chagan Solanki as Additional Director (Non-Executive and Non- Independent) and Mr. Altaf Hussain Shah as Additional Director (Non-Executive and Independent).
Tue, 14 Nov 2023
Submission Of Compliance As Per Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
As per Regulation 23(9) SEBI(LODR) Regulation 2015 we are hereby submitting the Disclosure of Related party transactions for the half year ended 30th September 2023.

Welcure Drugs & Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
High Increase in 5 Years High Increase in 5 Years
Close Crossing 200 SMA From Below Close Crossing 200 SMA From Below

Welcure Drugs & Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 269,302.46 2,362.70 +0.2%
Honasa Consumer Ltd. 12,858.61 400.20 -4.0%
Redington Ltd. 12,472.26 159.65 -0.6%
MMTC Ltd. 7,734.00 51.55 +2.5%
Lloyds Enterprises Ltd. 5,004.55 39.34 +5.0%
Landmark Cars Ltd. 3,183.88 777.85 -0.6%
Optiemus Infracom Ltd. 2,877.50 335.15 +6.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-09 110.18 2,362.70 +0.2%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 400.20 -4.0%
Redington Ltd. Consolidated 2023-09 10.04 159.65 -0.6%
MMTC Ltd. Consolidated 2023-09 44.42 51.55 +2.5%
Lloyds Enterprises Ltd. Consolidated 2023-09 67.17 39.34 +5.0%
Landmark Cars Ltd. Consolidated 2023-09 41.27 777.85 -0.6%
Optiemus Infracom Ltd. Consolidated 2023-09 64.53 335.15 +6.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-09 7.34 2,362.70 +0.2%
Honasa Consumer Ltd. Consolidated 2023-03 20.22 400.20 -4.0%
Redington Ltd. Consolidated 2023-09 1.81 159.65 -0.6%
MMTC Ltd. Consolidated 2023-09 5.35 51.55 +2.5%
Lloyds Enterprises Ltd. Consolidated 2023-09 3.48 39.34 +5.0%
Landmark Cars Ltd. Consolidated 2023-09 6.30 777.85 -0.6%
Optiemus Infracom Ltd. Consolidated 2023-09 7.46 335.15 +6.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 1.16 2,362.70 +0.2%
Honasa Consumer Ltd. Consolidated 2023-03 0.01 400.20 -4.0%
Redington Ltd. Consolidated 2023-03 0.45 159.65 -0.6%
MMTC Ltd. Consolidated 2023-03 0.14 51.55 +2.5%
Lloyds Enterprises Ltd. Consolidated 2023-03 0.06 39.34 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 0.45 777.85 -0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 0.14 335.15 +6.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 2,362.70 +0.2%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 400.20 -4.0%
Redington Ltd. Consolidated 2023-03 22.66 159.65 -0.6%
MMTC Ltd. Consolidated 2023-03 247.70 51.55 +2.5%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 39.34 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 24.15 777.85 -0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 11.75 335.15 +6.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.08 2,362.70 +0.2%
Honasa Consumer Ltd. Consolidated 2023-03 0.00 400.20 -4.0%
Redington Ltd. Consolidated 2023-03 22.66 159.65 -0.6%
MMTC Ltd. Consolidated 2023-03 247.70 51.55 +2.5%
Lloyds Enterprises Ltd. Consolidated 2023-03 5.19 39.34 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 24.15 777.85 -0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 11.75 335.15 +6.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 136,977.76 2,362.70 +0.2%
Honasa Consumer Ltd. Consolidated 2023-03 1,492.75 400.20 -4.0%
Redington Ltd. Consolidated 2023-03 79,376.78 159.65 -0.6%
MMTC Ltd. Consolidated 2023-03 3,528.18 51.55 +2.5%
Lloyds Enterprises Ltd. Consolidated 2023-03 380.30 39.34 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 3,382.35 777.85 -0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 1,173.88 335.15 +6.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 2,208.94 2,362.70 +0.2%
Honasa Consumer Ltd. Consolidated 2023-03 -150.97 400.20 -4.0%
Redington Ltd. Consolidated 2023-03 1,439.39 159.65 -0.6%
MMTC Ltd. Consolidated 2023-03 1,562.27 51.55 +2.5%
Lloyds Enterprises Ltd. Consolidated 2023-03 45.03 39.34 +5.0%
Landmark Cars Ltd. Consolidated 2023-03 85.10 777.85 -0.6%
Optiemus Infracom Ltd. Consolidated 2023-03 41.88 335.15 +6.9%

Welcure Drugs & Pharmaceuticals Ltd. FAQ's

What is Welcure Drugs&Pharma share price?
Can I buy Welcure Drugs&Pharma shares now?
What is the Market Cap of Welcure Drugs&Pharma?
What are the key metrics to analyse Welcure Drugs&Pharma?
What is the 52 Week High and Low of Welcure Drugs&Pharma?
What is the trend of Welcure Drugs&Pharma share price?